Targeted Therapeutics Under Investigation For PAH Treatment

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

PH_targeted

In a world where vasodilators rule the landscape of treatments for pulmonary arterial hypertension (PAH), scientific research groups and pharmaceutical companies around the world are working to develop targeted therapeutics that focus on specific cellular pathways that are associated with dysfunction in PAH patients. Within the realm of targeted therapeutics, certain therapies are in basic research and others are at moderate-to-advanced stages of clinical trials.

 

Read more about it: http://bit.ly/1PafX1J

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

pulmonary arterial hypertension (PAH), Pulmonary hypertension (PHT)

Recent Posts


Recommended reading